Intra Cellular Therapies | Egenkapital Og Reserver

Equity Capital And Reserves Lave om Dato
Acadia Pharmaceuticals USD 431.76M 69.58M 2023-12
ALKERMES USD 1.36B 75.15M 2023-09
Biogen USD 14.8B 315.6M 2023-12
Bristol-Myers Squibb USD 29B 2.98B 2023-09
Cytokinetics USD -386323000 52.48M 2023-12
Gilead Sciences USD 22.75B 435M 2023-12
Halozyme Therapeutics USD 83.81M 165.37M 2023-12
Intra Cellular Therapies USD 591.42M 9.26M 2023-12
Neurocrine Biosciences USD 2B 149.1M 2023-09
RedHill Biopharma USD 3.47M 1.47M 2023-06
Supernus Pharmaceuticals USD 921.52M 9.32M 2023-12
United Therapeutics USD 5.98B 272.7M 2023-12



Intra Cellular Therapies Egenkapital Og Reserver - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.